← Moelis & Co
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||||||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||||||||
| Net Income From Continuing Operations | — | — | — | — | — | — | $168.7m | ($27.5m) | $151.5m | $259.6m | |
| Net Income (Loss) Available to Common Stockholders, Basic | $38.4m | $29.4m | $140.7m | $105.1m | $178.8m | $365.2m | $150.3m | ($24.7m) | $136.0m | $233.0m | |
| Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | $141.9m | $126.5m | $208.0m | $135.7m | $218.4m | $423.0m | $168.7m | ($27.5m) | $151.5m | $259.6m | |
| Net Income (Loss) Attributable to Noncontrolling Interest | $103.5m | $97.1m | $67.3m | $30.6m | $39.6m | $57.8m | $18.3m | ($2.8m) | $15.5m | $26.6m | |
| Depreciation and amortization | $3.2m | $3.5m | $4.6m | $5.0m | $4.7m | $7.2m | $8.0m | $8.3m | $10.4m | $11.9m | |
| Depreciation, Nonproduction | $3.2m | $3.5m | — | — | — | — | — | — | — | — | |
| Depreciation Amortization Depletion | — | — | — | — | — | — | $8.0m | $8.3m | $10.4m | $11.9m | |
| Deferred Income Tax Expense (Benefit) | ($1.0m) | $191.7m | $6.5m | $3.7m | $39.0m | $22.9m | $26.8m | ($4.3m) | $35.1m | $50.0m | |
| Deferred Income Tax | — | — | — | — | — | — | $26.8m | ($4.3m) | $35.1m | $50.0m | |
| Deferred Tax | — | — | — | — | — | — | $26.8m | ($4.3m) | $35.1m | $50.0m | |
| Share-based Payment Arrangement, Noncash Expense | $77.0m | $96.3m | $123.0m | $124.2m | $133.6m | $167.9m | $128.9m | $158.2m | $161.4m | $230.3m | |
| Payment, Tax Withholding, Share-based Payment Arrangement | — | $12.3m | — | — | — | — | — | — | — | — | |
| Share-based Payment Arrangement, Expense | — | — | — | $123.4m | $133.6m | $167.9m | $128.9m | $158.2m | $161.4m | $230.3m | |
| Asset Impairment Charge | — | — | — | — | — | — | $2.6m | $1.1m | $1.6m | $739k | |
| Equity Method Investment, Realized Gain (Loss) on Disposal | — | — | — | — | — | — | — | — | — | $19.1m | |
| Income (Loss) from Equity Method Investments | $5.1m | $8.3m | $7.2m | — | — | — | — | — | — | — | |
| Income Tax Expense (Benefit) | $24.8m | $223.8m | $30.4m | $11.8m | $51.7m | $113.3m | $47.6m | ($1.6m) | $44.5m | $67.9m | |
| Earnings (Loss)es From Equity Investments | — | — | — | — | — | — | ($2.9m) | $0 | ($7.0m) | ($19.1m) | |
| Changes in operating assets and liabilities: | |||||||||||
| Additional Financial Items | |||||||||||
| Increase (Decrease) in Accounts Receivable | ($5.5m) | $35.6m | ($963k) | ($7.1m) | $46.7m | ($26.9m) | $20.3m | $4.0m | $1.8m | $31.2m | |
| Distributions paid to shareholders | $154.7m | $255.7m | $313.8m | $209.2m | $282.9m | $480.0m | $174.7m | $182.2m | $184.2m | — | |
| Equity Securities, FV-NI, Realized Gain (Loss) | — | — | — | — | — | $30.1m | $2.9m | — | — | — | |
| Gain (Loss) on Investments | — | — | — | — | — | $9.9m | — | — | — | — | |
| Nonoperating Income (Expense) | $509k | $177.7m | $4.5m | $33.0m | $4.4m | $40.4m | $220k | $11.2m | $23.1m | $53.6m | |
| Operating Expenses | $452.3m | $520.3m | $659.1m | $632.0m | $677.6m | $1.0b | $769.2m | $895.1m | $1.0b | $1.2b | |
| Proceeds from Stock Options Exercised | — | $6.1m | $6.8m | $21.5m | $11.9m | — | — | — | — | — | |
| Unrealized Gain (Loss) on Investments | ($249k) | ($465k) | — | — | — | — | — | — | — | — | |
| Beginning Cash Position | — | — | — | — | — | — | $521.0m | $207.5m | $187.2m | $413.2m | |
| Cash Flow From Continuing Financing Activities | — | — | — | — | — | — | ($326.9m) | ($229.2m) | ($215.1m) | ($283.9m) | |
| Cash Flow From Continuing Investing Activities | — | — | — | — | — | — | ($11.2m) | $48.6m | $17.1m | ($196.0m) | |
| Change In Account Payable | — | — | — | — | — | — | ($45.0m) | $23.7m | $21k | $18.2m | |
| Change In Other Working Capital | — | — | — | — | — | — | ($535k) | ($5.1m) | ($316k) | ($10.1m) | |
| Change In Payable | — | — | — | — | — | — | ($300.3m) | $38.6m | $87.1m | $109.5m | |
| Change In Payables And Accrued Expense | — | — | — | — | — | — | ($300.3m) | $38.6m | $87.1m | $109.5m | |
| Change In Prepaid Assets | — | — | — | — | — | — | ($15.0m) | $5.3m | ($4.4m) | ($8.9m) | |
| Change In Receivables | — | — | — | — | — | — | $1.7m | ($7.9m) | ($4.6m) | ($36.8m) | |
| Change In Working Capital | — | — | — | — | — | — | ($314.1m) | $31.0m | $77.7m | $53.8m | |
| Changes In Account Receivables | — | — | — | — | — | — | ($20.3m) | ($4.0m) | ($1.8m) | ($31.2m) | |
| Changes In Cash | — | — | — | — | — | — | ($305.1m) | ($22.1m) | $229.5m | $96.4m | |
| End Cash Position | — | — | — | — | — | — | $207.5m | $187.2m | $413.2m | $509.4m | |
| Financing Cash Flow | — | — | — | — | — | — | ($326.9m) | ($229.2m) | ($215.1m) | ($283.9m) | |
| Free Cash Flow | — | — | — | — | — | — | $27.0m | $141.8m | $415.4m | $540.0m | |
| Investing Cash Flow | — | — | — | — | — | — | ($11.2m) | $48.6m | $17.1m | ($196.0m) | |
| Net Business Purchase And Sale | — | — | — | — | — | — | $0 | $0 | $17.0m | $29.9m | |
| Net PPE Purchase And Sale | — | — | — | — | — | — | ($6.0m) | ($16.7m) | ($12.1m) | ($36.3m) | |
| Operating Gains Losses | — | — | — | — | — | ($30.1m) | ($2.9m) | — | ($7.0m) | ($19.1m) | |
| Other Non Cash Items | — | — | — | — | — | — | $9.2m | ($11.4m) | ($6.5m) | ($13.3m) | |
| Proceeds From Stock Option Exercised | — | — | — | — | — | $0 | $0 | — | — | — | |
| Purchase Of PPE | $2.9m | $5.6m | $6.9m | $6.5m | $40.7m | $16.4m | ($6.0m) | ($16.7m) | ($12.1m) | ($36.3m) | |
| Repurchase Of Capital Stock | — | — | — | — | — | — | ($147.5m) | ($47.0m) | ($10.8m) | ($74.6m) | |
| Sale Of Business | — | — | — | — | — | — | $0 | $0 | $17.0m | $29.9m | |
| Stock Based Compensation | — | — | — | — | — | — | $128.9m | $158.2m | $161.4m | $230.3m | |
| Net Cash Provided by (Used in) Operating Activities | $231.5m | $233.2m | $390.9m | $209.3m | $429.2m | $937.0m | $33.0m | $158.5m | $427.5m | $576.3m | |
| Cash flows from investing activities: | |||||||||||
| Payments to Acquire Property, Plant, and Equipment | $2.9m | $5.6m | $6.9m | $6.5m | $40.7m | $16.4m | $6.0m | $16.7m | $12.1m | $36.3m | |
| Net Investment Purchase And Sale | — | — | — | — | — | — | ($2.2m) | $65.3m | $18.8m | ($189.0m) | |
| Purchase Of Investment | — | — | — | — | — | — | ($334.7m) | ($210.6m) | ($169.5m) | ($524.8m) | |
| Sale Of Investment | — | — | — | — | — | — | $332.5m | $275.8m | $188.3m | $335.8m | |
| Net Other Investing Changes | — | — | — | — | — | $70k | ($3.0m) | — | ($6.6m) | ($595k) | |
| Net Cash Provided by (Used in) Investing Activities | — | ($69.4m) | $9.3m | ($51.9m) | ($40.0m) | ($17.0m) | ($11.2m) | $48.6m | $17.1m | ($196.0m) | |
| Cash flows from financing activities: | |||||||||||
| Net Common Stock Issuance | — | — | — | — | — | — | ($147.5m) | ($47.0m) | ($10.8m) | ($74.6m) | |
| Payments for Repurchase of Common Stock | $3.3m | — | — | — | — | — | — | — | — | — | |
| Payments of Ordinary Dividends, Common Stock | $155 | $256 | $314 | $209 | $283 | $480 | $175 | $182 | $184 | — | |
| Common Stock Payments | — | — | — | — | — | — | ($147.5m) | ($47.0m) | ($10.8m) | ($74.6m) | |
| Dividends Payable | $68 | — | — | — | — | — | — | — | — | — | |
| Cash Dividends Paid | — | — | — | — | — | — | ($174.7m) | ($182.2m) | ($184.2m) | ($208.7m) | |
| Common Stock Dividend Paid | — | — | — | — | — | — | ($174.7m) | ($182.2m) | ($184.2m) | ($208.7m) | |
| Dividend Received CFO | — | — | — | — | — | — | $2.9m | $3.1m | $3.1m | $2.3m | |
| Proceeds from (Payments for) Other Financing Activities | — | — | — | — | — | $200k | $1.9m | ($15k) | $0 | ($288k) | |
| Net Other Financing Charges | — | — | — | — | — | — | ($4.7m) | ($15k) | ($20.1m) | ($602k) | |
| Net Cash Provided by (Used in) Financing Activities | — | ($272.5m) | ($351.7m) | ($252.7m) | ($351.8m) | ($602.5m) | ($326.9m) | ($229.2m) | ($215.1m) | ($283.9m) | |
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | — | — | ($555k) | $2.1m | ($2.8m) | $305k | ($8.4m) | $1.8m | ($3.5m) | ($243k) | |
| Effect Of Exchange Rate Changes | — | — | — | — | — | — | ($8.4m) | $1.8m | ($3.5m) | ($243k) | |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | — | — | $47.9m | ($93.2m) | $34.7m | $317.7m | ($313.5m) | ($20.3m) | $226.0m | $96.2m | |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | — | — | $261.8m | $168.6m | $203.3m | $521.0m | $207.5m | $187.2m | $413.2m | $509.4m | |
| Supplemental disclosure of cash flow information: | |||||||||||
| Change In Cash Supplemental As Reported | — | — | — | — | — | — | ($313.5m) | ($20.3m) | $226.0m | $96.2m | |
| Income Taxes Paid, Net | — | $31.8m | $23.5m | $13.4m | ($305k) | $55.2m | $76.4m | ($3.6m) | $2.6m | $9.3m |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.